NO993948D0 - Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser - Google Patents
Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelserInfo
- Publication number
- NO993948D0 NO993948D0 NO993948A NO993948A NO993948D0 NO 993948 D0 NO993948 D0 NO 993948D0 NO 993948 A NO993948 A NO 993948A NO 993948 A NO993948 A NO 993948A NO 993948 D0 NO993948 D0 NO 993948D0
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- cns disorders
- derivatives against
- against cns
- cyclohexylamine derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98115484 | 1998-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993948D0 true NO993948D0 (no) | 1999-08-17 |
NO993948L NO993948L (no) | 2000-02-21 |
Family
ID=8232474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993948A NO993948L (no) | 1998-08-18 | 1999-08-17 | Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser |
Country Status (24)
Country | Link |
---|---|
US (1) | US6184236B1 (no) |
JP (1) | JP3455142B2 (no) |
KR (1) | KR100341194B1 (no) |
CN (1) | CN1141936C (no) |
AR (1) | AR021770A1 (no) |
AT (1) | ATE326219T1 (no) |
AU (1) | AU756408B2 (no) |
BR (1) | BR9903779A (no) |
CA (1) | CA2280455A1 (no) |
DE (1) | DE69931316D1 (no) |
HR (1) | HRP990256A2 (no) |
HU (1) | HUP9902737A3 (no) |
ID (1) | ID23107A (no) |
IL (1) | IL131399A0 (no) |
MA (1) | MA26677A1 (no) |
MY (1) | MY133133A (no) |
NO (1) | NO993948L (no) |
NZ (1) | NZ337243A (no) |
PE (1) | PE20000955A1 (no) |
PL (1) | PL334949A1 (no) |
SG (1) | SG82014A1 (no) |
TR (1) | TR199902015A2 (no) |
YU (1) | YU38699A (no) |
ZA (1) | ZA995212B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0111267A (pt) * | 2000-06-06 | 2003-12-16 | Warner Lambert Co | Cicloexilaminas bicìclicas e seu uso como antagonistas do receptor de nmda |
EP1436258A4 (en) * | 2001-03-08 | 2005-03-23 | Univ Emory | PH VALVE DEPENDENT NMDA RECEPTOR ANTAGONISTS |
DE10153345A1 (de) * | 2001-10-29 | 2003-05-08 | Gruenenthal Gmbh | Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen |
US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
US8420680B2 (en) * | 2007-06-29 | 2013-04-16 | Emory University | NMDA receptor antagonists for neuroprotection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4032766A1 (de) | 1990-10-16 | 1992-04-30 | Basf Ag | Phenylpiperidinoylamine und diese enthaltende arzneimittel |
DE4117904A1 (de) | 1991-05-31 | 1992-12-03 | Basf Ag | Substituierte n-phenylpiperidine |
EP0503411B1 (de) | 1991-03-14 | 1995-11-29 | BASF Aktiengesellschaft | Substituierte N-Phenylpiperidine und Arzneimittel daraus |
EP0940387B1 (en) | 1995-10-26 | 2003-05-07 | Mitsubishi Pharma Corporation | Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
-
1999
- 1999-08-09 US US09/370,602 patent/US6184236B1/en not_active Expired - Fee Related
- 1999-08-09 AT AT99115114T patent/ATE326219T1/de not_active IP Right Cessation
- 1999-08-09 DE DE69931316T patent/DE69931316D1/de not_active Expired - Lifetime
- 1999-08-13 AR ARP990104079A patent/AR021770A1/es not_active Application Discontinuation
- 1999-08-13 PE PE1999000826A patent/PE20000955A1/es not_active Application Discontinuation
- 1999-08-13 CA CA002280455A patent/CA2280455A1/en not_active Abandoned
- 1999-08-13 IL IL13139999A patent/IL131399A0/xx unknown
- 1999-08-13 NZ NZ337243A patent/NZ337243A/xx unknown
- 1999-08-16 JP JP22965899A patent/JP3455142B2/ja not_active Expired - Fee Related
- 1999-08-16 ZA ZA9905212A patent/ZA995212B/xx unknown
- 1999-08-16 ID IDP990791A patent/ID23107A/id unknown
- 1999-08-16 YU YU38699A patent/YU38699A/sh unknown
- 1999-08-16 MY MYPI99003508A patent/MY133133A/en unknown
- 1999-08-16 SG SG9903973A patent/SG82014A1/en unknown
- 1999-08-16 HU HU9902737A patent/HUP9902737A3/hu unknown
- 1999-08-17 MA MA25736A patent/MA26677A1/fr unknown
- 1999-08-17 AU AU44537/99A patent/AU756408B2/en not_active Ceased
- 1999-08-17 KR KR1019990033814A patent/KR100341194B1/ko not_active Expired - Fee Related
- 1999-08-17 PL PL99334949A patent/PL334949A1/xx not_active Application Discontinuation
- 1999-08-17 NO NO993948A patent/NO993948L/no unknown
- 1999-08-17 BR BR9903779-3A patent/BR9903779A/pt not_active IP Right Cessation
- 1999-08-17 CN CNB991179110A patent/CN1141936C/zh not_active Expired - Fee Related
- 1999-08-18 TR TR1999/02015A patent/TR199902015A2/xx unknown
- 1999-08-18 HR HR98115484.2A patent/HRP990256A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP3455142B2 (ja) | 2003-10-14 |
YU38699A (sh) | 2002-03-18 |
AU4453799A (en) | 2000-05-04 |
NZ337243A (en) | 2000-12-22 |
AR021770A1 (es) | 2002-08-07 |
DE69931316D1 (de) | 2006-06-22 |
ATE326219T1 (de) | 2006-06-15 |
IL131399A0 (en) | 2001-01-28 |
ZA995212B (en) | 2000-02-18 |
PE20000955A1 (es) | 2000-09-28 |
JP2000109429A (ja) | 2000-04-18 |
US6184236B1 (en) | 2001-02-06 |
ID23107A (id) | 2000-02-24 |
AU756408B2 (en) | 2003-01-09 |
NO993948L (no) | 2000-02-21 |
PL334949A1 (en) | 2000-02-28 |
MA26677A1 (fr) | 2004-12-20 |
CA2280455A1 (en) | 2000-02-18 |
HU9902737D0 (en) | 1999-10-28 |
KR100341194B1 (ko) | 2002-06-20 |
CN1141936C (zh) | 2004-03-17 |
HUP9902737A2 (hu) | 2000-06-28 |
HRP990256A2 (en) | 2000-04-30 |
KR20000017343A (ko) | 2000-03-25 |
MY133133A (en) | 2007-10-31 |
BR9903779A (pt) | 2000-09-19 |
HUP9902737A3 (en) | 2001-01-29 |
TR199902015A3 (tr) | 2000-03-21 |
TR199902015A2 (xx) | 2000-03-21 |
SG82014A1 (en) | 2001-07-24 |
CN1248439A (zh) | 2000-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
ATE245158T1 (de) | Bicyclische hydroxamsäurederivate | |
FI963761L (fi) | Kefalosporiinin synteesi | |
NO20011083L (no) | Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH | |
NO20001387L (no) | FremgangsmÕte for syntese av kinolinderivater | |
DK1224163T3 (da) | Anvendelse af carbonylaminoderivater mod CNS-lidelser | |
NO993948D0 (no) | Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser | |
NO20026005L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
NO20011892L (no) | 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser | |
NO20030127L (no) | Indolderivater nyttige for behandling av CNS-forstyrrelser | |
NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
NO20026029L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
NO20014845D0 (no) | Anvendelse av arylalkanoylpyridaziner | |
ATE243218T1 (de) | 2''-deoxyhygromycinderivate | |
NO20026028L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
NO20016030D0 (no) | Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin | |
NO20013044D0 (no) | Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater | |
BR9704770A (pt) | Derivados de 1-carba-(detia)-cefalosporina | |
FI953860A0 (fi) | Yhdistelmäpalkki | |
FI980433A0 (fi) | Foerfarande foer utnyttjande i samband med tillslutandet av en vaetskefoerpackning | |
FI943432A0 (fi) | Tillverkning av plastroerelement foersett med loesmuffoerbandsmedel | |
FI3524U1 (fi) | Yhdistelmäkoura | |
FI980484A0 (fi) | Foerfarande foer blaeddring av hypertextssidor med en mobilteleapparat | |
UA25486A (uk) | Мехаhізм архімедової спіралі | |
DK82798A (da) | Treatment of GABA-uptake related disorders |